Join to access to all OVN content. Join for Free

Fuel Progress

Dive into the collective wisdom, insights, and strategies from experts in pharma and biotech.

Start Exploring

Medical Voice Network
Medical Voice Network

OVN Podcasts

Podcast
Trust, Transparency & Timelines: Advancing Cancer Care
OVN Avatar Kirk Shepard
Trust, Transparency & Timelines: Advancing Cancer Care
Podcast
Busting Silos: Building the Future of Oncology Drug Development
OVN Avatar Ramin Farhood
Busting Silos: Building the Future of Oncology Drug Development

Trending on OVN

01

OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Apr 8th • 4 mins read

02

OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Apr 7th • 12 mins read

03

Partner Avatar iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care

May 16th • 5 mins read

04

OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Feb 23rd • 8 mins read

05

OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

May 6th • 18 mins read

06

Partner Avatar iNIZIO
Virtual Oncology MSL Team Increases KOL Engagement by 120%

Sep 3rd • 1 min read


Featured Articles

medical-judgment-at-the-point-of-decision
Partner Avatar Leon Rozen
Medical Judgment at the Point of Decision

Feb 12th • 5 mins read

launch-readiness-is-an-organisational-capability
Partner Avatar Leon Rozen
Launch Readiness Is an Organisational Capability

Feb 12th • 5 mins read

business-acumen-is-not-strategic-judgment
Partner Avatar Leon Rozen
Business Acumen Is Not Strategic Judgment

Feb 11th • 5 mins read

driving-therapeutic-impact-a-novel-model-for-strategic-medical-affairs-integration
OVN Avatar Ramin Farhood, Len Walt, Dani Thomas
Driving Therapeutic Impact: A Novel Model for Strategic Medical Affairs Integration

Jul 30th • 12 mins read

leading-from-the-front-3-leadership-lessons-from-mark-cuban
Partner Avatar Michael Pietrack
Leading From the Front: 3 Leadership Lessons From Mark Cuban

Dec 17th • 6 mins read

Related Topics

Loading...

Blog
Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology
Breaking Silos in Oncology Dr Ramin Farhood & Dr Kirk Shepard on Voices of Oncology

In this episode of The Authority Company Podcast, host Joe Pardavila sits down with Dr. Ramin Farhood and Dr. Kirk Shepard, co-authors of Voices of Oncology and co-founders of the...

Blog
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

We are proud to announce the forthcoming publication of Voices of Oncology — a first-of-its-kind collection of expert perspectives from across the oncology ecosystem, arriving July 2025 in partnership with...

Blog
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard
Visionaries Behind Oncology Voice Network: Dr. Ramin Farhood & Dr. Kirk Shepard

At the heart of the Oncology Voice Network (OVN) is a powerful mission: to unify oncology leaders across disciplines and accelerate the development of solutions that truly serve patients. Driving...